Found: 114
Select item for more details and to access through your institution.
Obecné zásady vakcinace u pacientů s RS uvádí doporučení Výboru Sekce klinické neuroimunologie a likvorologie ČNS ČLS JEP (vydáno 6. 3. 2021).
- Published in:
- Remedia, 2021, v. 31, n. 3, p. 272
- By:
- Publication type:
- Article
Komentář: Efekt DMT na rozvoj disability u relabující-remitující roztroušené sklerózy v průběhu 15 let.
- Published in:
- Remedia, 2021, n. 2, p. 178
- By:
- Publication type:
- Article
Komentář: Efekt DMT na rozvoj disability u relabující‑remitující roztroušené sklerózy v průběhu 15 let.
- Published in:
- Remedia, 2021, v. 31, n. 1, p. 178
- By:
- Publication type:
- Article
Komentář: Vyšetřování kognitivních funkcí u pacientů s roztroušenou sklerózou.
- Published in:
- Remedia, 2020, n. 5, p. 513
- By:
- Publication type:
- Article
The clinical and paraclinical correlates of employment status in multiple sclerosis.
- Published in:
- Neurological Sciences, 2022, v. 43, n. 3, p. 1911, doi. 10.1007/s10072-021-05553-z
- By:
- Publication type:
- Article
Additive Effect of Spinal Cord Volume, Diffuse and Focal Cord Pathology on Disability in Multiple Sclerosis.
- Published in:
- Frontiers in Neurology, 2019, p. 1, doi. 10.3389/fneur.2019.00820
- By:
- Publication type:
- Article
Interní komorbidity a komplikace terapie roztroušené sklerózy – nenechte se zaskočit!
- Published in:
- Internal Medicine / Vnitrni Lekarstvi, 2023, v. 69, n. 5, p. 294
- By:
- Publication type:
- Article
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 11, p. 4633, doi. 10.1093/brain/awad218
- By:
- Publication type:
- Article
Delay from treatment start to full effect of immunotherapies for multiple sclerosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Early clinical markers of aggressive multiple sclerosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Defining secondary progressive multiple sclerosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Defining reliable disability outcomes in multiple sclerosis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Brainstem lesions are associated with diffuse spinal cord involvement in early multiple sclerosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2020, p. 1, doi. 10.1177/2055217320972137
- By:
- Publication type:
- Article
Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2020, v. 6, n. 4, p. 1, doi. 10.1177/2055217320972137
- By:
- Publication type:
- Article
Interpretation of Brain Volume Increase in Multiple Sclerosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Role of High-Frequency MRI Monitoring in the Detection of Brain Atrophy in Multiple Sclerosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effect of FGFR inhibitors on chicken limb development.
- Published in:
- Development, Growth & Differentiation, 2014, v. 56, n. 8, p. 555, doi. 10.1111/dgd.12156
- By:
- Publication type:
- Article
Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.818325
- By:
- Publication type:
- Article
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2024, p. 1, doi. 10.1177/17562864231221331
- By:
- Publication type:
- Article
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231198963
- By:
- Publication type:
- Article
Lexical and syntactic deficits analyzed via automated natural language processing: the new monitoring tool in multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231180719
- By:
- Publication type:
- Article
Lexical and syntactic deficits analyzed via automated natural language processing: the new monitoring tool in multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, v. 16, p. 1, doi. 10.1177/17562864231180719
- By:
- Publication type:
- Article
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, v. 16, p. 1, doi. 10.1177/17562864231198963
- By:
- Publication type:
- Article
Cesta k datům: Stanoviska a doporučení pro poskytování zdravotních dat pro sekundární využití.
- Published in:
- Journal of Czech Physicians / Časopis Lékařů Českých, 2023, v. 162, n. 2/3, p. 61
- By:
- Publication type:
- Article
Standardizace využití MR v diagnostice a monitoraci roztroušené sklerózy v České republice.
- Published in:
- Czech Radiology / Ceska Radiologie, 2024, v. 78, n. 2, p. 101
- By:
- Publication type:
- Article
MxA mRNA decrease preceding NAb detection in IFNβ-treated MS patients.
- Published in:
- Brain & Behavior, 2017, v. 7, n. 3, p. n/a, doi. 10.1002/brb3.644
- By:
- Publication type:
- Article
Reliable measurements of brain atrophy in individual patients with multiple sclerosis.
- Published in:
- Brain & Behavior, 2016, v. 6, n. 9, p. n/a, doi. 10.1002/brb3.518
- By:
- Publication type:
- Article
Comparative effectiveness in multiple sclerosis: A methodological comparison.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 3, p. 326, doi. 10.1177/13524585231151394
- By:
- Publication type:
- Article
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 2, p. 221, doi. 10.1177/13524585221137502
- By:
- Publication type:
- Article
Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 11, p. 1752, doi. 10.1177/13524585221084577
- By:
- Publication type:
- Article
Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 13, p. 2001, doi. 10.1177/13524585211047977
- By:
- Publication type:
- Article
Determinants of therapeutic lag in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 12, p. 1838, doi. 10.1177/1352458520981300
- By:
- Publication type:
- Article
Disability outcomes of early cerebellar and brainstem symptoms in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 5, p. 755, doi. 10.1177/1352458520926955
- By:
- Publication type:
- Article
Neurofilament levels are associated with blood–brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 2, p. 220, doi. 10.1177/1352458520912379
- By:
- Publication type:
- Article
Serum neurofilament light chain reflects inflammation-driven neurodegeneration and predicts delayed brain volume loss in early stage of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 1, p. 52, doi. 10.1177/1352458519901272
- By:
- Publication type:
- Article
Risk of secondary progressive multiple sclerosis: A longitudinal study.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 1, p. 79, doi. 10.1177/1352458519868990
- By:
- Publication type:
- Article
International consensus on quality standards for brain health-focused care in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 13, p. 1809, doi. 10.1177/1352458518809326
- By:
- Publication type:
- Article
Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 541, doi. 10.1177/1352458517742739
- By:
- Publication type:
- Article
Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 12, p. 1617, doi. 10.1177/1352458517728812
- By:
- Publication type:
- Article
Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 5, p. 642, doi. 10.1177/1352458517703800
- By:
- Publication type:
- Article
Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 10, p. 1346, doi. 10.1177/1352458516679893
- By:
- Publication type:
- Article
Is no evidence of disease activity an achievable goal in MS patients on intramuscular interferon beta-1a treatment over long-term follow-up?
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 2, p. 242, doi. 10.1177/1352458516650525
- By:
- Publication type:
- Article
Contribution of different relapse phenotypes to disability in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 2, p. 266, doi. 10.1177/1352458516643392
- By:
- Publication type:
- Article
Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 1, p. 51, doi. 10.1177/1352458516642314
- By:
- Publication type:
- Article
A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 13, p. 1709, doi. 10.1177/1352458516629769
- By:
- Publication type:
- Article
Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 6, p. 770, doi. 10.1177/1352458515601903
- By:
- Publication type:
- Article
The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 4, p. 520, doi. 10.1177/1352458515594041
- By:
- Publication type:
- Article